Statins and Macular Degeneration
This study, presented at ARVO 2026, suggests that high-intensity statin therapy significantly lowers the risk of progression from intermediate to "wet" age-related macular degeneration (AMD) . Researchers believe statins may slow the buildup of drusen —lipid-rich deposits under the retina—similar to how they manage plaques in heart disease. Key Study Findings Over a 30-month follow-up of 124 patients, the researchers observed: Reduced Risk: Statin users had a 46% lower risk of overall AMD progression compared to non-users. Wet AMD Prevention: High-intensity statin use specifically reduced the risk of converting to neovascular (wet) AMD by 70% . Vision Preservation: High-intensity users were 59% less likely to suffer significant visual acuity loss and showed better preservation of contrast sensitivity. Drusen Impact: Treatment was associated with a slower increase in drusen volume, though it did not appear to impact progression toward geographic atrophy (dry AMD). Cli...